
MNCs foresee tailwinds for vibrancy
The momentum generated by government policies aimed at stabilising foreign investment, combined with the rapid growth of green and artificial intelligence-driven economies, will deliver strong tailwinds for foreign companies in China this year, said foreign business executives.
With rising global economic headwinds and uncertainty over the United States' trade policies, many global enterprises are opting to consolidate their presence in China, with plans to maintain or expand investment.
China's stable and business-friendly environment supported a modest rebound in foreign direct investment in March, with actual FDI inflows into the Chinese mainland increasing by 13.2 percent year-on-year, data from the Ministry of Commerce showed.
Marelli Holdings Co Ltd, a Saitama, Japan-headquartered multinational automotive parts manufacturer with more than 50 manufacturing facilities across the world, will expand its engineering team from 800 to 1,000 in China over the next three years.
"Many opportunities arise from Chinese automakers' rapid shift toward electrification and intelligence, especially in the form of software-defined vehicles, which are setting new benchmarks for speed, scale and innovation," said David Slump, the group's president and CEO.
With China and the US agreeing to de-escalate trade tensions last week, Slump said that these two countries are major markets for Marelli.
"We are closely monitoring and assessing the situation, and are committed to minimising any impact on our operations and customers," said Slump. He added that the company is already exporting advanced products and solutions from China to other markets, including Europe, Mexico and Southeast Asia.
Also upbeat about the Chinese market, British pharmaceutical company AstraZeneca announced in March an investment of $2.5 billion to establish in Beijing its sixth global strategic R&D centre, and further expand its biotech innovation partnerships and local manufacturing capabilities.
The new facility will advance early-stage research and clinical development and will be enabled by a new AI and data science laboratory.
Susan Galbraith, executive vice-president, oncology R&D, Astra-Zeneca, said that having two of its six global strategic R&D centres in China reflects the group's confidence in China's world-class biomedical innovation ecosystem and reinforces the nation's critical role in its global R&D strategy.
Ji Wenhua, a professor at the Academy of China Open Economy Studies, which is part of the University of International Business and Economics in Beijing, said that China's well-developed industrial bases, strong supply chain resilience and policy emphasis on innovation continue to make it an attractive destination for global capital.
According to China's 2025 Action Plan for Stabilising Foreign Investment, the country will support pilot regions in effectively implementing opening-up policies related to areas such as value-added telecommunication, biotechnology and wholly foreign-owned hospitals, providing whole-journey services for foreign-invested projects in these sectors.
The action plan also supports foreign businesses to participate in China's new industrialisation, with a focus on high-tech fields. Global capital has been welcomed in service sectors such as elderly care, culture and tourism, sports, healthcare, vocational education and finance.
As part of its strategy to strengthen operations in China, US express transportation service provider FedEx Corp announced in mid-May that it would enhance its international export services from Shanghai.
The cutoff times for same-day outbound shipments from Shanghai to Europe, Asia-Pacific and the Middle East, India and Africa will be further extended.
The foreign trade value of foreign-invested businesses reached 4.1 trillion yuan ($567.51 billion) in China between January and April, up 1.9 percent year-on-year, accounting for 29 percent of China's total foreign trade value, statistics from the General Administration of Customs showed.
In the meantime, Jiangsu province, a major hub for foreign-invested companies, recorded 864.25 billion yuan in foreign trade value, up 7.2 percent year-on-year, according to Nanjing Customs. - China Daily/ANN
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


New Straits Times
27 minutes ago
- New Straits Times
Justice Dept accuses 2 Chinese researchers of smuggling 'potential agroterrorism weapon' into US
WASHINGTON: US federal prosecutors have accused two Chinese nationals of smuggling a dangerous biological pathogen that had the potential to be used as an agricultural terrorism weapon into the United States for research. The US Department of Justice on Tuesday identified the pathogen as Fusarium graminearum, a fungus it said was classified in scientific literature as a potential agroterrorism weapon. In a statement, it said that the fungus causes "head blight" in some crops and is responsible for billions of US dollars in economic losses globally each year. According to an FBI criminal complaint, Zunyong Liu, 34, a researcher currently in China, brought the fungus into the United States while visiting his girlfriend, Yunqing Jian, 33, in July 2024. He admitted to smuggling in the fungus so he could conduct research on it at a University of Michigan laboratory where his girlfriend worked, according to the complaint. The university did not immediately respond to a request for comment. According to the complaint, an examination of electronic communications between the two indicated that they discussed shipping biological materials and research being done in the laboratory prior to Liu's arrival. Jian and Liu were accused in the complaint of conspiracy, smuggling goods into the United States, false statements and visa fraud. Cheyvoryea Gibson, special agent in charge of the FBI Detroit Field Office, said the pair's actions "posed an imminent threat to public safety." Jian was expected to appear in court in Detroit, Michigan, on Tuesday. A judge appointed a public defender, who could not be immediately reached for comment, to represent Jian.


The Sun
42 minutes ago
- The Sun
Tesla UK Sales Fall 45% in May Despite BEV Market Growth
TESLA'S new car sales in Britain tumbled more than 45% from a year earlier in May, preliminary data from research group New AutoMotive showed on Wednesday. The automaker, which has been losing market share in part because of CEO Elon Musk's embrace of far-right politics in Europe, sold 1,758 units in Britain last month, down from 3,244 a year earlier, the data showed. Yet, Tesla remained the best-selling battery electric vehicle in Britain so far this year. Overall new car registrations in the UK increased 4.3% to 144,098 units in May, according to New AutoMotive, with BEV sales rising 28% year-on-year. Among Chinese rivals, BYD more than doubled its new car sales in the UK to 1,388 units during the month.


The Sun
43 minutes ago
- The Sun
Tesla's UK car sales drop over 45% in May, New AutoMotive early data shows
TESLA'S new car sales in Britain tumbled more than 45% from a year earlier in May, preliminary data from research group New AutoMotive showed on Wednesday. The automaker, which has been losing market share in part because of CEO Elon Musk's embrace of far-right politics in Europe, sold 1,758 units in Britain last month, down from 3,244 a year earlier, the data showed. Yet, Tesla remained the best-selling battery electric vehicle in Britain so far this year. Overall new car registrations in the UK increased 4.3% to 144,098 units in May, according to New AutoMotive, with BEV sales rising 28% year-on-year. Among Chinese rivals, BYD more than doubled its new car sales in the UK to 1,388 units during the month.